Search

Brian Ngo

Examiner (ID: 19153, Phone: (571)270-7011 , Office: P/2851 )

Most Active Art Unit
2851
Art Unit(s)
2825, 2851
Total Applications
1288
Issued Applications
1125
Pending Applications
69
Abandoned Applications
122

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 19338570 [patent_doc_number] => 12048741 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-07-30 [patent_title] => Recombinant host cell with heterologous nucleic acids encoding SHREK proteins [patent_app_type] => utility [patent_app_number] => 17/031082 [patent_app_country] => US [patent_app_date] => 2020-09-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 18 [patent_no_of_words] => 11072 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17031082 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/031082
Recombinant host cell with heterologous nucleic acids encoding SHREK proteins Sep 23, 2020 Issued
Array ( [id] => 16569216 [patent_doc_number] => 20210008222 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-01-14 [patent_title] => PLANT VIRUS PARTICLES FOR DELIVERY OF ANTIMITOTIC AGENTS [patent_app_type] => utility [patent_app_number] => 17/030793 [patent_app_country] => US [patent_app_date] => 2020-09-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9211 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17030793 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/030793
Plant virus particles for delivery of antimitotic agents Sep 23, 2020 Issued
Array ( [id] => 17865452 [patent_doc_number] => 20220288187 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-09-15 [patent_title] => BIODEGRADABLE NANOCOMPLEX VACCINES, METHODS FOR SUPPRESSION OF HEPAPITIS B VIRUS REPLICATION AND HEPAPITIS B VIRUS SURFACE ANTIGEN SECRETION [patent_app_type] => utility [patent_app_number] => 17/763184 [patent_app_country] => US [patent_app_date] => 2020-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5271 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17763184 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/763184
BIODEGRADABLE NANOCOMPLEX VACCINES, METHODS FOR SUPPRESSION OF HEPAPITIS B VIRUS REPLICATION AND HEPAPITIS B VIRUS SURFACE ANTIGEN SECRETION Sep 22, 2020 Abandoned
Array ( [id] => 19225483 [patent_doc_number] => 12005113 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-06-11 [patent_title] => Porcine epidemic diarrhea virus strains and immunogenic compositions therefrom [patent_app_type] => utility [patent_app_number] => 17/021261 [patent_app_country] => US [patent_app_date] => 2020-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 198 [patent_figures_cnt] => 236 [patent_no_of_words] => 40575 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 151 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17021261 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/021261
Porcine epidemic diarrhea virus strains and immunogenic compositions therefrom Sep 14, 2020 Issued
Array ( [id] => 17921628 [patent_doc_number] => 11464849 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-10-11 [patent_title] => Recombinant herpesvirus of turkey vectors expressing antigens of avian pathogens and uses thereof [patent_app_type] => utility [patent_app_number] => 17/017342 [patent_app_country] => US [patent_app_date] => 2020-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 35 [patent_figures_cnt] => 50 [patent_no_of_words] => 40258 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17017342 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/017342
Recombinant herpesvirus of turkey vectors expressing antigens of avian pathogens and uses thereof Sep 9, 2020 Issued
Array ( [id] => 16989387 [patent_doc_number] => 20210227807 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-07-29 [patent_title] => METHOD FOR DETECTION AND MITIGATION OF COMPOUND PRODUCING MICROBIOTA IN AN AQUACULTURE SYSTEM [patent_app_type] => utility [patent_app_number] => 16/992760 [patent_app_country] => US [patent_app_date] => 2020-08-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13289 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -22 [patent_words_short_claim] => 75 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16992760 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/992760
METHOD FOR DETECTION AND MITIGATION OF COMPOUND PRODUCING MICROBIOTA IN AN AQUACULTURE SYSTEM Aug 12, 2020 Abandoned
Array ( [id] => 18064479 [patent_doc_number] => 20220395566 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-12-15 [patent_title] => IMMUNOGENIC COMPOSITION [patent_app_type] => utility [patent_app_number] => 17/634272 [patent_app_country] => US [patent_app_date] => 2020-08-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 34956 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17634272 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/634272
IMMUNOGENIC COMPOSITION Aug 9, 2020 Abandoned
Array ( [id] => 16915858 [patent_doc_number] => 20210188950 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-06-24 [patent_title] => Antibodies Against F Glycoprotein of Hendra and Nipah Viruses [patent_app_type] => utility [patent_app_number] => 16/988835 [patent_app_country] => US [patent_app_date] => 2020-08-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16831 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16988835 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/988835
Antibodies against F glycoprotein of Hendra and Nipah viruses Aug 9, 2020 Issued
Array ( [id] => 17836487 [patent_doc_number] => 20220273792 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-09-01 [patent_title] => A METHOD OF ELICITING AN IMMUNE RESPONSE BY ADMINISTERING A POPULATION OF POLYMERSOMES HAVING AN ASSOCIATED ANTIGEN TOGETHER WITH A POPULATION OF POLYMERSOMES HAVING AN ASSOCIATED ADJUVANT AS WELL AS COMPOSITIONS COMPRISING THE TWO POPULATIONS OF POLYMERSOMES [patent_app_type] => utility [patent_app_number] => 17/631845 [patent_app_country] => US [patent_app_date] => 2020-08-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 56089 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17631845 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/631845
A METHOD OF ELICITING AN IMMUNE RESPONSE BY ADMINISTERING A POPULATION OF POLYMERSOMES HAVING AN ASSOCIATED ANTIGEN TOGETHER WITH A POPULATION OF POLYMERSOMES HAVING AN ASSOCIATED ADJUVANT AS WELL AS COMPOSITIONS COMPRISING THE TWO POPULATIONS OF POLYMERSOMES Aug 2, 2020 Pending
Array ( [id] => 16697899 [patent_doc_number] => 10948490 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2021-03-16 [patent_title] => Severe acute respiratory syndrome (SARS)--associated coronavirus diagnostics [patent_app_type] => utility [patent_app_number] => 16/944649 [patent_app_country] => US [patent_app_date] => 2020-07-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 18 [patent_no_of_words] => 11387 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 78 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16944649 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/944649
Severe acute respiratory syndrome (SARS)--associated coronavirus diagnostics Jul 30, 2020 Issued
Array ( [id] => 18732575 [patent_doc_number] => 11801295 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-10-31 [patent_title] => Immunogenic compositions and uses thereof [patent_app_type] => utility [patent_app_number] => 16/941481 [patent_app_country] => US [patent_app_date] => 2020-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 55 [patent_no_of_words] => 31740 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16941481 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/941481
Immunogenic compositions and uses thereof Jul 27, 2020 Issued
Array ( [id] => 17828504 [patent_doc_number] => 20220265808 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-08-25 [patent_title] => A PORCINE CIRCOVIRUS TYPE 2 (PCV2) VACCINE [patent_app_type] => utility [patent_app_number] => 17/628403 [patent_app_country] => US [patent_app_date] => 2020-07-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14984 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17628403 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/628403
A PORCINE CIRCOVIRUS TYPE 2 (PCV2) VACCINE Jul 26, 2020 Abandoned
Array ( [id] => 17355429 [patent_doc_number] => 20220016225 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-01-20 [patent_title] => VACCINE COMPOSITIONS AND ADJUVANT [patent_app_type] => utility [patent_app_number] => 16/933157 [patent_app_country] => US [patent_app_date] => 2020-07-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9309 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 78 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16933157 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/933157
VACCINE COMPOSITIONS AND ADJUVANT Jul 19, 2020 Abandoned
Array ( [id] => 18418586 [patent_doc_number] => 20230173044 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-06-08 [patent_title] => RECOMBINANT PROTEIN FOR REMOVING BOAR TAINT AND VACCINE COMPOSITION COMPRISING THE SAME [patent_app_type] => utility [patent_app_number] => 16/964632 [patent_app_country] => US [patent_app_date] => 2020-06-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7675 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16964632 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/964632
RECOMBINANT PROTEIN FOR REMOVING BOAR TAINT AND VACCINE COMPOSITION COMPRISING THE SAME Jun 28, 2020 Abandoned
Array ( [id] => 17881220 [patent_doc_number] => 20220296697 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-09-22 [patent_title] => PORCINE CIRCOVIRUS TYPE 2 VLP VACCINE [patent_app_type] => utility [patent_app_number] => 17/634488 [patent_app_country] => US [patent_app_date] => 2020-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9901 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17634488 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/634488
Porcine circovirus type 2 VLP vaccine Jun 22, 2020 Issued
Array ( [id] => 17297932 [patent_doc_number] => 20210393771 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-12-23 [patent_title] => VIRAL VACCINES FOR IN VIVO EXPRESSION OF A NUCLEIC ACIDS ENCODIND AN IMMUNOGENIC PEPTIDE AND METHODS OF USING THE SAME [patent_app_type] => utility [patent_app_number] => 16/909311 [patent_app_country] => US [patent_app_date] => 2020-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15603 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16909311 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/909311
Viral vaccines for in vivo expression of a nucleic acid encoding an immunogenic peptide and methods of using the same Jun 22, 2020 Issued
Array ( [id] => 18700100 [patent_doc_number] => 11786587 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-10-17 [patent_title] => Composition of subunit dengue vaccine [patent_app_type] => utility [patent_app_number] => 16/906134 [patent_app_country] => US [patent_app_date] => 2020-06-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 82 [patent_no_of_words] => 14150 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16906134 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/906134
Composition of subunit dengue vaccine Jun 18, 2020 Issued
Array ( [id] => 16555719 [patent_doc_number] => 20210000867 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-01-07 [patent_title] => NEW ROUTE AND ENGINEERING PROTOCOLS FOR ALZHEIMERS DISEASE PREVENTION, TREATMENT AND NEURONAL REBUILDING [patent_app_type] => utility [patent_app_number] => 16/906450 [patent_app_country] => US [patent_app_date] => 2020-06-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10806 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16906450 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/906450
NEW ROUTE AND ENGINEERING PROTOCOLS FOR ALZHEIMERS DISEASE PREVENTION, TREATMENT AND NEURONAL REBUILDING Jun 18, 2020 Abandoned
Array ( [id] => 17775058 [patent_doc_number] => 20220241407 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-08-04 [patent_title] => MINI-COMBINED ADJUVANTS CARRIER-FREE NANOPARTICLES AND REPARATION METHOD AND APPLICATION THEREOF [patent_app_type] => utility [patent_app_number] => 17/256095 [patent_app_country] => US [patent_app_date] => 2020-06-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2284 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17256095 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/256095
MINI-COMBINED ADJUVANTS CARRIER-FREE NANOPARTICLES AND REPARATION METHOD AND APPLICATION THEREOF Jun 16, 2020 Abandoned
Array ( [id] => 17090919 [patent_doc_number] => 11119103 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2021-09-14 [patent_title] => Serological assays for SARS-CoV-2 [patent_app_type] => utility [patent_app_number] => 16/900798 [patent_app_country] => US [patent_app_date] => 2020-06-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 15852 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 134 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16900798 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/900798
Serological assays for SARS-CoV-2 Jun 11, 2020 Issued
Menu